Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Purpose of review: Hundreds of millions of people worldwide are exposed to arsenic via contaminated water. The goal of this study was to identify whether arsenic-associated lung function deficits resemble obstructive- or restrictive-like lung disease, in order to help illuminate a mechanistic pathway and identify at-risk populations. Recent findings: We recently published a qualitative systematic review outlining the body of research on arsenic and non-malignant respiratory outcomes. Evidence from several populations, at different life stages, and at different levels of exposure showed consistent associations of arsenic exposure with chronic lung disease mortality, respiratory symptoms, and lower lung function levels. The published review, however, only conducted a broad qualitative description of the published studies without considering specific spirometry patterns, without conducting a meta-analysis, and without evaluating the dose-response relationship. Summary: We searched PubMed and Embase for studies on environmental arsenic exposure and lung function. We performed a meta-analysis using inverse-variance weighted random-effects models to summarize adjusted effect estimates for arsenic and forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio. Across nine studies, median water arsenic levels ranged from 23 to 860 μg/L. The pooled estimated mean difference (MD) comparing the highest category of arsenic exposure (ranging from >11 to >800 μg/L) versus the lowest (ranging from <10 to <100 μg/L) for each study for FEV1 was −42 (95% confidence interval (CI): −70, −16) mL and for FVC was −50 (95%CI: −63, −37) mL. Three studies reported effect estimates for FEV1/FVC, for which there was no evidence of an association; the pooled estimated MD was 0.01 (95%CI: −0.005, 0.024). This review supports that arsenic is associated with restrictive impairments based on inverse associations between arsenic and FEV1 and FVC, but not with FEV1/FVC. Future studies should confirm whether low-level arsenic exposure is a restrictive lung disease risk factor in order to identify at-risk populations in the US.
Purpose of review: Hundreds of millions of people worldwide are exposed to arsenic via contaminated water. The goal of this study was to identify whether arsenic-associated lung function deficits resemble obstructive- or restrictive-like lung disease, in order to help illuminate a mechanistic pathway and identify at-risk populations. Recent findings: We recently published a qualitative systematic review outlining the body of research on arsenic and non-malignant respiratory outcomes. Evidence from several populations, at different life stages, and at different levels of exposure showed consistent associations of arsenic exposure with chronic lung disease mortality, respiratory symptoms, and lower lung function levels. The published review, however, only conducted a broad qualitative description of the published studies without considering specific spirometry patterns, without conducting a meta-analysis, and without evaluating the dose-response relationship. Summary: We searched PubMed and Embase for studies on environmental arsenic exposure and lung function. We performed a meta-analysis using inverse-variance weighted random-effects models to summarize adjusted effect estimates for arsenic and forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio. Across nine studies, median water arsenic levels ranged from 23 to 860 μg/L. The pooled estimated mean difference (MD) comparing the highest category of arsenic exposure (ranging from >11 to >800 μg/L) versus the lowest (ranging from <10 to <100 μg/L) for each study for FEV1 was −42 (95% confidence interval (CI): −70, −16) mL and for FVC was −50 (95%CI: −63, −37) mL. Three studies reported effect estimates for FEV1/FVC, for which there was no evidence of an association; the pooled estimated MD was 0.01 (95%CI: −0.005, 0.024). This review supports that arsenic is associated with restrictive impairments based on inverse associations between arsenic and FEV1 and FVC, but not with FEV1/FVC. Future studies should confirm whether low-level arsenic exposure is a restrictive lung disease risk factor in order to identify at-risk populations in the US.
ABSTRACT:Spatial point pattern is one of the most suitable methods for analysing groundwater arsenic concentrations. Groundwater arsenic poisoning in Bangladesh has been one of the biggest environmental health disasters in recent times. About 85 million people are exposed to arsenic more than 50μg/L in drinking water. The paper seeks to identify the existing suitable aquifers for arsenic-safe drinking water along with "spatial arsenic discontinuity" using GIS-based spatial geostatistical analysis in a small study site (12.69 km 2 ) in the coastal belt of southwest Bangladesh (Dhopakhali union of Bagerhat district). The relevant spatial data were collected with Geographical Positioning Systems (GPS), arsenic data with field testing kits, tubewell attributes with observation and questionnaire survey. Geostatistics with kriging methods can design water quality monitoring in different aquifers with hydrochemical evaluation by spatial mapping. The paper presents the interpolation of the regional estimates of arsenic data for spatial discontinuity mapping with Ordinary Kriging (OK) method that overcomes the areal bias problem for administrative boundary. This paper also demonstrates the suitability of isopleth maps that is easier to read than choropleth maps. The OK method investigated that around 80 percent of the study site are contaminated following the Bangladesh Drinking Water Standards (BDWS) of 50μg/L. The study identified a very few scattered "pockets" of arsenic-safe zone at the shallow aquifer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.